A database of publications about African genetic resources and digital sequence information — real bibliographic metadata pulled from PubMed, with a durable link back to the source record. Papers that aren't on PubMed, given by curators as evidence, are listed beside them from Crossref, linked by their DOI to the publisher. Full text is frequently paywalled even when the abstract/metadata is open, so this is a metadata catalog with an outbound link, not a hosted archive; this platform never claims to host or redistribute full text.
Epidemiology of inflammatory bowel disease in the Middle East and North Africa: a multinational, tertiary care registry (MIRAGE) study.
Shehab M, Azzam N, Al-Hindawi A, Alrashed F, Al-Bawardy B, Abid S, Bashandi AA, AlShihri RM, Mukhtar M, Saadah O, Alharbi O, Al-Darmaki A, Al Harthi S, Al-Ejji K, Ayash A, Al Sahli A, Khamees N, Salem OE, Mohamed EA, Maher M, Daba G, Helal AA, Abdulhakim Alnassar M, Alfadhli A, Quraishi MN, Goodwin SW, Yuan Y, Mosli M, Jairath V · J Crohns Colitis (2026)
Egypt · DOI: 10.1093/ecco-jcc/jjag145
Inflammatory bowel disease (IBD) is increasing in the Middle East and North Africa (MENA), yet region-specific evidence on phenotype and treatment patterns remains limited. We aimed to characterize IBD epidemiology, clinical phenotypes, and therapy use across MENA centers.
This was a multicenter cross-sectional study across 13 centers in seven MENA countries. Adults with ulcerative colitis (UC), Crohn's disease (CD), or IBD-unclassified (IBD-U) were included. Demographics, Montreal phenotype/behavior, smoking status, disease duration, perianal disease, and therapies were collected. Descriptive statistics and between-group comparisons were performed.
We analyzed 10 340 patients (52% UC, 45% CD, 3% IBD-U). Mean age was 39.79 ± 14.4 years in UC and 34.57 ± 12.9 years in CD (P < .0001). UC patients were slightly more often female (51.6%), while CD patients were male-predominant (59.0%). Current smoking was more common in CD than in UC (12.0% vs 5.6%). Mean disease duration was 9.73 ± 7.5 years, longest in Jordan (14.1 years) and shortest in Qatar (2.45 years; P < .001). Biologic exposure differed by subtype (P < .001), with the highest rate in CD (57.9%). In UC, extensive colitis (E3) was the most common phenotype. In CD, ileocolonic involvement (L3) predominated with mainly non-stricturing, non-penetrating behavior (B1). Perianal disease affected approximately 13% overall, with rates varying by country, highest in UAE and lowest in Egypt and Qatar.
This multi-country hospital-based registry study helps define contemporary IBD patterns in MENA: slight UC predominance, high rates of extensive UC and ileocolonic B1 CD, and heterogeneous biologic use. Our data provide insights into regional IBD epidemiological trends and treatment adoption.
Trehalose attenuates experimental L-arginine-induced acute pancreatitis in mice by modulating the expression of autophagy-related markers: Beclin-1, LC3-II, and p62/SQSTM1.
Arafat EA, Elsayed HRH, Nasr A, Alghamdi MA, Elhessy HM, El-Desoky MM, Mostafa N, Shabaan DA · Tissue Cell (2026)
Egypt · DOI: 10.1016/j.tice.2026.104006
Acute pancreatitis (AP) is one of the most common gastrointestinal emergencies, with a fatality rate reaching 30%. Many studies reported defective autophagy in AP. Trehalose, a disaccharide, has been shown to reduce inflammatory injury by restoring autophagy; however, few studies have examined its ability to enhance autophagy in L-arginine-induced AP. Twenty-four adult male Swiss albino mice were assigned to 3 groups: a control group, an L-arginine group, and an L-arginine + trehalose group (2 g/kg once daily for 12 days). Seventy-two hours after the last treatment, all mice were dissected, and blood samples were collected for pancreatic enzyme assessment. Histological assessment and histopathological scoring for pancreatic tissues were performed. To assess autophagic machinery, an immunohistochemical study using antibodies against LC3-II and P62/SQSTM1 was performed, and mRNA expression of the Beclin-1 and LC3-II genes in pancreatic tissues was assessed. The L-arginine group demonstrated significant increases in serum pancreatic lipase and amylase levels (P < 0.001), distortion of the exocrine acini, inflammatory cell infiltration, areas of necrosis, and many autophagic vacuoles. Immunohistochemical analysis showed a significant increase in the percentage of areas occupied by LC3-II and P62 (P < 0.001) and in the gene expression of Beclin-1 and LC3-II compared with the control group (P < 0.001). Compared to the L-arginine group, the L-arginine + trehalose group revealed a significant reduction in serum pancreatic lipase and amylase levels (P < 0.001), intact exocrine acini, and minimal inflammatory cell infiltration, with a significant reduction in the immunohistochemical area percentages of LC3-II and P62 (P < 0.001), and in Beclin-1 and LC3-II gene expressions (P < 0.001). In conclusion, trehalose therapy significantly mitigates pancreatic injury by restoring effective autophagy.
Ethical Challenges with Comprehensive, Integrated, and Universal Preimplantation Genetic Testing Platforms Utilizing Whole Genome Sequencing (PGT-WGS).
Chin AHB, Alon I, Bosenge-Nguma JD, Sun N, Yang J · Asian Bioeth Rev (2026)
Congo · DOI: 10.1007/s41649-025-00368-y
Recent advances in preimplantation genetic testing (PGT) and whole genome amplification technologies have resulted in the development of comprehensive platforms that integrate multiple types of PGT utilizing whole genome sequencing (PGT-WGS). These platforms combine PGT-A, PGT-M, PGT-SR, and PGT-P into a single universal genetic screening system for IVF embryos. Leveraging cutting-edge computing and artificial intelligence technologies, PGT-WGS allows simultaneous screening for aneuploidies, monogenic disorders, chromosomal structural rearrangements, and polygenic disease risks using a single trophectoderm biopsy from a blastocyst-stage embryo. The popularization of Newborn Genomic Sequencing (NBSeq) for the early diagnosis and treatment of rare genetic disorders will likely promote extensive uptake of PGT-WGS among IVF patients because many prospective parents will rationalize that "prevention is better than cure." While this technology platform provides the opportunity to select the "best and healthiest" IVF embryo based on the optimal genetic profile, it also raises profound ethical issues. Due to commercial interests, profit-driven private fertility clinics will likely advocate for extensive, indiscriminate, and non-judicious use of universal PGT-WGS in the future, regardless of appropriate medical indications, such as family history of genetic diseases, recurrent miscarriages, or repeated IVF failures. This concern is amplified by findings from large randomized clinical trials, which have repeatedly demonstrated that the broad application of PGT-A does not significantly improve IVF success rates, which can be extrapolated to PGT-WGS in the future. There are also concerns about the lack of evidence for the usefulness and effectiveness of the PGT-P component of PGT-WGS. Moreover, the identification of recessive monogenic disease gene loci in a significant number of IVF embryos via PGT-WGS may cause unnecessary confusion and distress to some ill-informed patients. Hence, the ethical implications of the potential widespread, indiscriminate, and non-judicious use of universal PGT-WGS will be examined, focusing on its possible harms and the need for balanced and comprehensive patient counseling.
Aflatoxin contamination of maize remains a global food safety and public health challenge, particularly because it is a dietary staple food and feed ingredient produced across diverse agroecological zones. Although numerous mitigation strategies have been developed, contamination levels remain variable. This reflects complex interactions among climate, soil properties, crop management practices, plant physiological stress and rhizosphere microbial communities. This review synthesizes evidence on key agroecological drivers of aflatoxin contamination in maize, highlighting climate variability, soil properties, crop and nutrient management, cropping systems, and rhizosphere microbial communities as primary determinants. We examine how these factors influence Aspergillus population dynamics, microbial interactions and aflatoxin biosynthesis across contrasting production environments. Evidence synthesized in this review indicates that inconsistent outcomes of existing management including biological control strategies largely arise from insufficient consideration of soil-plant-microbe interactions and spatial heterogeneity. We identify climatic stress, soil properties and crop management strategies as the dominant determinants of aflatoxin risk, acting through biological mediators such as plant physiological status, rhizosphere microbial communities and fungal population. The review argues that effective and scalable aflatoxin mitigation requires integrated, context-specific and systems-based approaches. We conclude that incorporating agroecological heterogeneity into research design, predictive models and management frameworks is essential for improving risk prediction and developing aflatoxin control strategies in maize-based cropping systems.
From predicted bacteriocins to ecological function.
Wayah SB, Arakawa K, Philip K · Curr Res Microb Sci (2026)
Nigeria · DOI: 10.1016/j.crmicr.2026.100662
Genome and metagenome mining have uncovered large repertoires of predicted bacteriocin loci, but ecological interpretation has lagged behind discovery. This review uses bacteriocins as a focused model for a broader problem in antimicrobial gene prediction: sequence identifies encoded potential, but it does not establish expression, product deployment, target engagement, or community-level consequence. We distinguish four forms of bacteriocin "silence": transcriptional silence, where loci are not detectably expressed under tested conditions; conditional silence, where expression or activity emerges only under specific environmental or social cues; phenotypic silence, where expression or product formation does not yield detectable activity in routine assays; and ecological silence, where activity is observed but its consequences for coexistence, exclusion, colonization, or community assembly remain unresolved. We also clarify how this framework extends previous reviews of bacteriocin diversity and microbiome-shaping roles by providing an inference-centered taxonomy that separates encoded potential from demonstrated ecological function. Finally, we propose a function-first roadmap for bacteriocin research, including condition-resolved transcriptomics and proteomics, promoter and cue-dissection experiments, expanded target panels, spatially structured assays, defined consortia and microcosms, producer/non-producer comparisons, and explicit tests of resistance, immunity, and fitness consequences. Treating predicted bacteriocin loci as hypotheses rather than conclusions will improve how the field moves from gene catalogs to causal ecological understanding.
Genomic insights into carbapenemase- and extended-spectrum β-lactamase-producing gram-negative bacteria in aquatic and terrestrial animal reservoirs in the United Arab Emirates.
Khalifa HO, Mohammed T, Ramadan H, Abdalla A, Joseph AM, Mannina N, Kishore U, Willingham AL · One Health (2026)
Egypt · DOI: 10.1016/j.onehlt.2026.101582
The global spread of carbapenemase- and extended-spectrum β-lactamase (ESBL)-producing Gram-negative bacteria represents a major One Health challenge, driven by interconnected human, animal, and environmental reservoirs. However, genomic data on antimicrobial-resistant bacteria associated with aquatic and terrestrial animals in the United Arab Emirates (UAE) remain scarce, limiting assessment of their potential role in resistance dissemination. This study investigated the phenotypic and genomic characteristics of resistant Gram-negative bacteria recovered from these animal reservoirs.
Sixty aquarium-associated samples were collected, yielding 69 Gram-negative isolates. Antimicrobial susceptibility testing, phenotypic detection of ESBL and carbapenemase activity, molecular screening of resistance genes, and whole-genome sequencing of selected isolates were performed. Phylogenetic analyses were conducted to assess evolutionary relatedness with global strains.
The isolates were mainly identified as Citrobacter, Pseudomonas, Acinetobacter, and Escherichia coli. Resistance to β-lactam antibiotics was widespread, with 87% of isolates confirmed as ESBL producers and 37.7% classified as multidrug resistant. Carbapenemase activity was detected in 14.5% of isolates. Genomic analyses revealed diverse ESBL, AmpC, and carbapenemase genes, including bla CTX-M-15, bla CTX-M-55, bla CMY-82, bla NDM-1, and for the first time multiple OXA-type carbapenemases (bla OXA-51, bla OXA-421, and bla OXA-848, bla OXA-1005, bla OXA-211-like, and bla OXA-396-like), frequently associated with mobile genetic elements. ESBL-producing E. coli ST602 and ST10 clustered closely with human, food, wildlife, and environmental strains from national and international sources.
Aquatic and terrestrial animals in the UAE serve as important reservoirs for clinically relevant antimicrobial resistance. These findings underscore the need for integrated One Health genomic surveillance to mitigate the transboundary spread of high-risk resistant lineages.
Surveillance-Driven Machine Learning for Prediction of Antimicrobial Susceptibility: An Explainable Modeling Framework using the Pfizer ATLAS Dataset (2004 - 2023).
Mutua R, Gichohi D, Ndegwa SK, Golicha RO, Njeru F, Kituku B · Wellcome Open Res (2026)
Kenya · DOI: 10.12688/wellcomeopenres.26477.2
Antimicrobial resistance (AMR) is a growing global public health threat, particularly in low- and middle-income countries (LMICs), where delayed antimicrobial susceptibility testing (AST) and limited diagnostic capacity complicate timely treatment and antimicrobial stewardship (AMS). Although large-scale surveillance programmes routinely collect antimicrobial susceptibility data, these datasets remain underutilised for predictive analytics.
We developed a surveillance-driven machine learning (ML) framework using isolate-level data from African sites participating in the Pfizer Antimicrobial Testing Leadership and Surveillance (ATLAS) programme between 2019 and 2023. Seven antibiotic-specific Extreme Gradient Boosting (XGBoost) models were developed to predict antimicrobial susceptibility using routinely collected microbiological, demographic, clinical, and geographical metadata. Model development included structured data preprocessing, RandomOverSampler-based class balancing restricted to the training data, hyperparameter optimisation using stratified cross-validation, and evaluation on a held-out test dataset. A rule-based MIC interpretation system and interactive dashboard were developed to demonstrate implementation of the analytical workflow.
The antibiotic-specific models demonstrated moderate predictive performance, with test accuracies ranging from 57% to 76%. Ceftazidime-Avibactam achieved the highest test accuracy (76%), followed by Gentamicin (65%) and Imipenem (64%), while Amikacin showed the lowest performance (57%). Feature-importance analysis identified bacterial species as consistently among the most influential predictors. In contrast, bacterial family, country of isolate collection, specimen source, clinical specialty, and demographic characteristics contributed to varying degrees across antibiotics. Performance was generally stronger for the more frequently represented susceptible class than for intermediate and resistant isolates.
Routinely collected AMR surveillance data can support antibiotic-specific ML predictions without requiring genomic sequencing or detailed patient-level clinical information. This study provides a proof-of-concept framework for surveillance-driven predictive analytics that could complement conventional AMR surveillance and AMS. External validation, calibration, prospective clinical evaluation, and implementation studies are required before routine deployment.
Antimicrobial resistance (AMR) occurs when bacteria no longer respond to medicines used to treat infections, making illnesses harder to treat and increasing the risk of severe outcomes. This is a growing global health problem, particularly in Low- and Middle-Income Countries (LMICs) where access to rapid diagnostic testing and Antimicrobial Stewardship (AMS) programs may be limited. In many healthcare settings, laboratory testing to determine which antibiotics are effective can take 48–72 hours. During this time, patients are often treated with broad-spectrum antibiotics without knowing whether they will work. This can lead to unnecessary antibiotic use, higher treatment costs, and the development of further resistance. This study explored whether routinely collected AMR surveillance data can be used to predict antibiotic effectiveness. Using data from the Pfizer ATLAS surveillance program, we developed computer-based models that estimate the likelihood that a specific antibiotic will be effective against a bacterial infection. These predictions are based on factors such as the type of bacteria, geographic location, and sample source. We also developed a rule-based tool that interprets laboratory measurements into standard susceptibility categories and an interactive dashboard that allows users to explore resistance trends and model predictions in a user-friendly way. The results show that surveillance data can be used to generate meaningful predictions about antibiotic effectiveness, even without advanced laboratory or genomic data. These tools could support earlier and more informed treatment decisions, improve antibiotic use, and strengthen monitoring of resistance patterns. However, the accuracy of these predictions depends on the quality and completeness of available data, and further validation is needed before routine clinical use. Overall, this study demonstrates how existing surveillance data can be transformed into practical tools to support better use of antibiotics and help slow the spread of antimicrobial resistance, particularly in resource-limited settings.
Carbohydrate-active enzymes from a core root mycobiota member enable infection of multiple plant hosts.
Raja-Kumar RS, Mesny F, Basak AK, Newfeld J, Chesneau G, Entila F, Lee T, Rigerte L, Carvajal Acevedo S, Hüttel B, Crous PW, Maciá-Vicente JG, Stewart H, Ryan M, Fakhoury AM, Sacristán S, Aitouguinane M, Batisson I, Dumontet S, Elmer WH, Henzelyová J, Kruszewska JS, Nelson JM, Santelli CM, Pauly M, Molina A, Hiruma K, Hacquard S · Nat Microbiol (2026)
South Africa · DOI: 10.1038/s41564-026-02492-3
The root microbiome includes fungal pathogens capable of colonizing multiple plant hosts, yet the underlying genetic determinants remain unknown. Here we report that Plectosphaerella cucumerina is a core member of the Arabidopsis thaliana root microbiota, which displays pathogenic potential across multiple hosts. Using a collection of 72 Plectosphaerella isolates and whole-genome sequencing, we observed subtle phenotypic and genotypic variation associated with fungal phylogeny but not host plant identity. Transcriptome profiling of a P. cucumerina isolate in roots of diverse plants revealed core and host-specific fungal responses, including induction of carbohydrate-active enzymes (CAZymes) involved in root cell wall deconstruction. A fungal gene encoding a candidate β-1,3-glucanase (GH64) was identified as a key genetic factor driving multihost infection. This gene is present across plant-colonizing fungi and functions as a disease determinant in both P. cucumerina and a Colletotrichum root pathogen. Our results indicate that host-induced CAZymes can couple fungal virulence with multihost compatibility.
Multivariate analysis of 110 green super rice (GSR) lines for morpho-physiological diversity attributes.
Ahmed MS, Abdelghany AM, Majeed A, Siddique F, Lamlom SF, Javaid RA, Hassan HJ · BMC Plant Biol (2026)
Egypt · DOI: 10.1186/s12870-025-08049-6
Genetic diversity present in rice genotypes plays a crucial role in improving breeding strategies and developing high-quality cultivars. This study evaluated genetic diversity, agronomic performance, and disease resistance across 110 unique rice cultivars over two growing seasons (2021-2022) using an alpha-lattice design. Ten morpho-physiological and yield characteristics were assessed along with resistance to brown leaf spot (BLS) in natural field conditions. The combined analysis of variance indicated highly significant genotypic effects (P < 0.01) across all traits, with broad-sense heritability values varying from 8.83% for days to maturity to 45.56% for plant height. K-means clustering effectively categorized genotypes into five distinct groups. Cluster 4 demonstrated the highest yield at 10.64 t ha⁻¹, characterized by early flowering, whereas Cluster 5 attained significant productivity of 10.2 t ha⁻¹ due to its large grain size. The distribution of BLS resistance demonstrated considerable variation across clusters (χ² = 50.1, P < 0.001). Cluster 1 presented 60% highly resistant genotypes, while Cluster 2 displayed 60% resistant genotypes, with no entries classified as susceptible. Notable performers comprised NGSR.18 with a multi-trait score of 70.77%, GSR1 achieving a yield of 12.76 t ha⁻¹, and GSR34, GSR49, GSR50 exhibiting high resistance to BLS. The correlation analysis demonstrated genetic independence between yield and disease resistance, thereby supporting the feasibility of simultaneous improvement. The findings offer significant genetic resources for the development of high-yielding, disease-resistant rice cultivars.
Biological Biomarkers in Proliferative Verrucous Leukoplakia: A Systematic Review and Meta-Analysis.
Alkeheli MF, Othman HI · Oral Dis (2026)
Egypt · DOI: 10.1111/odi.70520
To synthesise biological biomarker evidence in proliferative verrucous leukoplakia/proliferative leukoplakia and quantify malignant transformation using eligible longitudinal evidence.
Primary human biomarker studies and longitudinal studies reporting extractable malignant-transformation events and denominators were systematically reviewed. Biomarker evidence was synthesised narratively. Malignant-transformation proportions were pooled using a random-effects model, with conservative handling of potentially overlapping cohorts.
Forty-one publications contributed to the biomarker synthesis, spanning genetic, genomic, DNA-ploidy, epigenetic, transcriptomic, proteomic, immunohistochemical, immunologic, viral, microbiome, salivary, and circulating markers. No biomarker had sufficient independent validation for clinical diagnostic or prognostic use. Twenty independent or conservatively non-overlapping study estimates comprising 745 patients and 243 malignant-transformation events contributed to the meta-analysis. The pooled malignant-transformation proportion was 34.13% (95% confidence interval 26.62-42.53), with substantial heterogeneity and a 95% prediction interval of 13.85%-62.56%. Results remained stable in sensitivity and leave-one-out analyses.
Diverse biological alterations have been reported, but none currently supports routine biomarker-based diagnosis or individual risk stratification. Malignant transformation is frequent, although substantial between-study variability limits interpretation of the pooled estimate as an individual patient risk.